We found that the expression levels of IFI27, MSRB2, and SCO2 were significantly higher in SLE patients compared to normal controls, while the levels of FAM210B and LYRM7 were significantly lower, as determined by the Wilcoxon rank-sum test (Fig. 6A). The gene discussed is MSRB2; the disease is systemic lupus erythematosus.